Current Affairs - Science - Discussion

Bharat Biotech has launched the oral cholera vaccine, Hillchol, following successful phase 3 trials that demonstrated its safety. The vaccine was developed under license from Hilleman Laboratories and aims to address the global shortage of cholera vaccine doses. With a production capacity of 200 million doses, Hillchol targets individuals above the age of one, providing a crucial solution to combat cholera globally. Bharat Biotech's launch of Hillchol marks a significant milestone in the fight against cholera.